Mater Medical Research Institute (MMRI) is a world class institute established in 1998. Driven by a ‘bench to bedside’ philosophy, MMRI's leading scientists work alongside doctors to turn basic scientific discovery into better treatment for patients, from babies to adults. Upholding the values of its founders, the Sisters of Mercy, MMRI focuses on cancer and immunology; mucosal/inflammatory bowel diseases; stem cell and bone marrow transplant; clinical trials for prostate cancer and multiple myeloma; obesity, diabetes and heart disease. Core expertise and capabilities include: ovarian cancer and diagnostics; haematopoietic and mesenchymal stem cells; insulin sensitivity and metabolism in obesity and type II diabetes; anti-dendritic cell antibodies; and mucin proteins and IBD.